Genitourinary Cancer Incidence and Mortality Varies by Region, Race, and Sex
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
All articles by Andrea S. Blevins Primeau, PhD, MBA
The Role of Single-Arm Trials in Oncology Drug Approvals
Oncology drug approvals in the United States are increasingly supported by single-arm clinical trials, a study suggests.
Racial Disparities in Radiotherapy Regimens for Prostate and Breast Cancer
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Patients May Not Understand Medical Jargon Used to Describe Cancer
Some patients do not understand common phrases oncologists use, such as “your tumor is progressing” or “your nodes are positive.”
Adjuvant Nivolumab-Ipilimumab Failed to Improve DFS in Renal Cell Carcinoma
Nivolumab plus ipilimumab did not prolong disease-free survival, and 43% of patients discontinued treatment due to toxicities.
COSMIC-313: Triplet Prolongs PFS vs Doublet in Renal Cell Carcinoma
The PFS benefit was driven primarily by patients with intermediate-risk disease.
MRI-Based Assessment May Eliminate Need for TURBT in Muscle-Invasive Bladder Cancer
MRI-based assessment shortened the time to correct treatment, when compared with TURBT, for patients with MIBC.
Longer Course of ADT With Postop Radiotherapy Improves Metastasis-Free Survival in Prostate Cancer
Adding a longer course of androgen deprivation therapy to postoperative radiotherapy may prolong metastasis-free survival in patients with prostate cancer.
Adverse Events Associated With Outcomes in PD-1/PD-L1–Treated Urothelial Carcinoma
An FDA pooled analysis suggests that certain AEs were associated with response and overall survival in PD-1/PD-L1-treated urothelial cancer.
Jury Still Out on Whether Immunotherapy Can Cure Metastatic RCC
Though uncommon, complete responses are seen among patients with metastatic disease, but CRs seem to occur more often with immune checkpoint inhibitors.
- Loading...
Loading...
Next post in Kidney Cancer
Loading... 
Loading...